Page 3 - Mark Enyedy News Today

ImmunoGen Inc shares rocketed higher Friday after the company’s first quarter sales impressed investors.  The Massachusetts-based company posted revenue of...

ImmunoGen, Inc. , a leader in the expanding field of antibody-drug conjugates for the treatment of cancer, today announced that Isabel Kalofonos has been appointed Senior Vice President and Chief... | June 18, 2023

ImmunoGen, Inc. (Nasdaq: IMGN), a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced that Isabel Kalofonos has been appointed Senior Vice President and Chief Commercial Officer. "We are excited to welcome Isabel to ImmunoGen's Executive Committee to lead ...

ImmunoGen to Receive $75 Million Upon Execution of the Agreement; Eligible to Receive up to an Additional $100 Million in Near-Term Proceeds ... | April 6, 2023

Operator: Good morning, and welcome to ImmunoGens Fourth Quarter and Full Year 2022 Financial and Operating Results Conference Call. Todays conference is being recorded.

(RTTNews) - ImmunoGen, Inc. (IMGN), Wednesday announced Renee Lentini, Vice President of Finance and Chief Accounting Officer, has been appointed ...

In regular places, when alarms blare and it becomes clear that a big, important something is broken and threatens folks’ well-being, those with common sense race to make needed fixes....

The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.

ImmunoGen Appoints Daniel Char as Senior Vice President and Chief Legal Officer - read this article along with other careers information, tips and advice on BioSpace

Program leverages NeoGenomics' expertise to provide ovarian cancer patients critical insights to ensure they are getting the right treatmentFT. MYERS, FL / ACCESSWIRE / November 18, 2022 / NeoGenomics